Clinical Trial

ANSN Symposium Redefines Astaxanthin Science and Innovation

BURLINGTON, N.J., Oct. 21, 2025 /PRNewswire/ -- AstaReal Inc. announces the first virtual symposium hosted by the AstaReal Network for…

2 months ago

Knowtex Selected by U.S. Department of Veterans Affairs to Deploy Ambient Clinical AI

Women-founded, YC-backed company, Knowtex brings ambient AI to the nation's largest integrated healthcare system SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/…

2 months ago

Alethios Launches to Lower the Barriers to Human Health Research

Alethios debuts with proven customers, strong study metrics, and the Alethios Study Planner — a $100/month tool making health evidence generation…

2 months ago

Pain Consultants of East Tennessee Selected as the Initial “Flagship Office” to Demonstrate the Power of the Adhere+ Remote Therapeutic Monitoring Platform

Flagship initiative aims to tackle Tennessee's chronic pain and opioid epidemic while generating real-world evidence to guide national adoption of…

2 months ago

Improving Translational Research and Clinical Trials with Digital Pathology, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how expert-led pathology supports translational research and clinical trials at every stage. Attendees will gain…

2 months ago

Beyond the bench: The advantages of GMP over USP compounding in early phase development, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insights about the differences between GMP and USP compounding in research. Attendees will learn that…

2 months ago

Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting

Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition…

2 months ago

Adia Nutrition Inc. Appoints Dr. Evan Thomas, MD, PhD, to Drive Adia Med’s Specialized Treatment Revolution

Winter Park, Florida--(Newsfile Corp. - October 21, 2025) -  Adia Nutrition Inc. (OTCQB: ADIA) is excited to announce the appointment…

2 months ago

Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies

Three Independent Studies Published in “Alzheimer’s Research & Therapy,” “Journal of Alzheimer’s Disease,” and “Radiology” Validate Nexalin’s Non-Invasive Approach with…

2 months ago

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout

MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO)…

2 months ago